Daesung Microbiological Labs. Co. Ltd Total Assets

Latest as of December 2025: ₩57.98 Billion KRW ≈ $39.29 Million USD

Daesung Microbiological Labs. Co. Ltd total assets. Based on the latest financial reports, Daesung Microbiological Labs. Co. Ltd (036480) holds total assets worth ₩57.98 Billion KRW (≈ $39.29 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Daesung Microbiological Labs. Co. Ltd (036480) market capitalisation for the company's overall valuation and market capitalisation.

Total Assets of Daesung Microbiological Labs. Co. Ltd (2012–2025)

Total assets of Daesung Microbiological Labs. Co. Ltd from 2012 to 2025. This chart illustrates how Daesung Microbiological Labs. Co. Ltd's total assets have evolved over time, based on quarterly financial data. See Daesung Microbiological Labs. Co. Ltd (036480) share price today for real-time trading data and today's change.

Daesung Microbiological Labs. Co. Ltd - Asset Composition Analysis

Daesung Microbiological Labs. Co. Ltd Total Assets Breakdown (December 2025)

Daesung Microbiological Labs. Co. Ltd total assets breakdown as of December 2025. Daesung Microbiological Labs. Co. Ltd's total assets of ₩57.98 Billion consist of 43.5% current assets and 56.5% non-current assets.

Asset Category	Amount (KRW)	% of Total Assets
Cash & Equivalents	₩0.00	5.9%
Accounts Receivable	₩5.02 Billion	8.7%
Inventory	₩10.55 Billion	18.2%
Property, Plant & Equipment	₩0.00	0.0%
Intangible Assets	₩428.67 Million	0.7%
Goodwill	₩0.00	0.0%

Asset Composition Trend (2012–2025)

This chart illustrates how Daesung Microbiological Labs. Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore 036480 current assets to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Daesung Microbiological Labs. Co. Ltd's current assets represent 43.5% of total assets in 2025, an increase from 41.6% in 2012.
Cash Position: Cash and equivalents constituted 5.9% of total assets in 2025, up from 5.1% in 2012.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2012.
Asset Diversification: The largest asset category is inventory at 18.2% of total assets.

Daesung Microbiological Labs. Co. Ltd Competitors by Total Assets

Key competitors of Daesung Microbiological Labs. Co. Ltd based on total assets are shown below.

Company	Country	Total Assets
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	USA	$1.26 Billion
Verona Pharma plc F:I9SA	Germany	€572.87 Million
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	USA	$641.76 Million
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	China	CN¥37.46 Billion
Metsera, Inc. Common Stock NASDAQ:MTSR	USA	$639.66 Million
Beijing Tiantan Biological Products Corp Ltd SHG:600161	China	CN¥16.55 Billion
Bavarian Nordic CO:BAVA	Denmark	Dkr14.95 Billion
Hebei Changshan Biochem Pharma SHE:300255	China	CN¥4.66 Billion

Daesung Microbiological Labs. Co. Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.96	5.22	6.73
Quick Ratio	1.72	2.90	4.06
Cash Ratio	0.00	0.80	0.00
Working Capital	₩16.70 Billion	₩19.11 Billion	₩19.31 Billion

Daesung Microbiological Labs. Co. Ltd - Advanced Valuation Insights

This section examines the relationship between Daesung Microbiological Labs. Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	0.77
Latest Market Cap to Assets Ratio	0.00
Asset Growth Rate (YoY)	-0.7%
Total Assets	₩57.98 Billion
Market Capitalization	$13.93 Million USD

Valuation Analysis

Below Book Valuation: The market values Daesung Microbiological Labs. Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Daesung Microbiological Labs. Co. Ltd's assets decreased by 0.7% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Daesung Microbiological Labs. Co. Ltd (2012–2025)

The table below shows the annual total assets of Daesung Microbiological Labs. Co. Ltd from 2012 to 2025.

Year	Total Assets	Change
2025-12-31	₩57.98 Billion ≈ $39.29 Million	-0.69%
2024-12-31	₩58.38 Billion ≈ $39.56 Million	-9.19%
2023-12-31	₩64.29 Billion ≈ $43.57 Million	-1.26%
2022-12-31	₩65.11 Billion ≈ $44.12 Million	+3.98%
2021-12-31	₩62.62 Billion ≈ $42.44 Million	+0.57%
2020-12-31	₩62.26 Billion ≈ $42.19 Million	+22.64%
2019-12-31	₩50.77 Billion ≈ $34.40 Million	+33.25%
2018-12-31	₩38.10 Billion ≈ $25.82 Million	+9.53%
2017-12-31	₩34.78 Billion ≈ $23.57 Million	-2.32%
2016-12-31	₩35.61 Billion ≈ $24.13 Million	+9.84%
2015-12-31	₩32.42 Billion ≈ $21.97 Million	+16.65%
2014-12-31	₩27.79 Billion ≈ $18.83 Million	-3.99%
2013-12-31	₩28.95 Billion ≈ $19.62 Million	+13.55%
2012-12-31	₩25.49 Billion ≈ $17.28 Million	--

About Daesung Microbiological Labs. Co. Ltd

KQ:036480 Korea Biotechnology

Market Cap

$13.93 Million

₩20.56 Billion KRW

Market Cap Rank

#26034 Global

#1941 in Korea

Share Price

₩5410.00

Change (1 day)

+0.00%

52-Week Range

₩5410.00 - ₩9880.00

All Time High

₩27216.09